Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation
- PMID: 32198567
- DOI: 10.1007/s10620-020-06208-3
Deoxycholic Acid-Induced Gut Dysbiosis Disrupts Bile Acid Enterohepatic Circulation and Promotes Intestinal Inflammation
Abstract
Background: A Western diet is a risk factor for the development of inflammatory bowel disease (IBD). High levels of fecal deoxycholic acid (DCA) in response to a Western diet contribute to bowel inflammatory injury. However, the mechanism of DCA in the natural course of IBD development remains unanswered.
Aims: The aim of this study is to investigate the effect of DCA on the induction of gut dysbiosis and its roles in the development of intestinal inflammation.
Methods: Wild-type C57BL/6J mice were fed an AIN-93G diet, either supplemented with or without 0.2% DCA, and killed at 24 weeks. Distal ileum and colon tissues were assessed by histopathological analysis. Hepatic and ileal gene expression was examined by qPCR, and the gut microbiota was analyzed by high-throughput 16S rRNA gene sequencing. HPLC-MS was used for fecal bile acid quantification.
Results: Mice fed the DCA-supplemented diet developed focal areas of ileal and colonic inflammation, accompanied by alteration of the composition of the intestinal microbiota and accumulation of fecal bile acids. DCA-induced dysbiosis decreased the deconjugation of bile acids, and this regulation was associated with the repressed expression of target genes in the enterohepatic farnesoid X receptor-fibroblast growth factor (FXR-FGF15) axis, leading to upregulation of hepatic de novo bile acid synthesis.
Conclusions: These results suggest that DCA-induced gut dysbiosis may act as a key etiologic factor in intestinal inflammation, associated with bile acid metabolic disturbance and downregulation of the FXR-FGF15 axis.
Keywords: Bile acids; Farnesoid X receptor; Fibroblast growth factor 15; Gut dysbiosis; Intestinal inflammation.
Similar articles
-
Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice.J Crohns Colitis. 2021 Jul 5;15(7):1197-1210. doi: 10.1093/ecco-jcc/jjab003. J Crohns Colitis. 2021. PMID: 33417675
-
Bad "Good" Bile Acids and Gut Microbiota Dysbiosis in Inflammatory Bowel Disease: Mice and Humans Are Not the Same.Dig Dis Sci. 2021 Mar;66(3):925-927. doi: 10.1007/s10620-020-06650-3. Epub 2020 Oct 16. Dig Dis Sci. 2021. PMID: 33063190
-
Secondary bile acid-induced dysbiosis promotes intestinal carcinogenesis.Int J Cancer. 2017 Jun 1;140(11):2545-2556. doi: 10.1002/ijc.30643. Epub 2017 Mar 1. Int J Cancer. 2017. PMID: 28187526
-
Bile Acid-Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside.Nutrients. 2021 Sep 9;13(9):3143. doi: 10.3390/nu13093143. Nutrients. 2021. PMID: 34579027 Free PMC article. Review.
-
Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer.Exp Biol Med (Maywood). 2014 Nov;239(11):1489-504. doi: 10.1177/1535370214538743. Epub 2014 Jun 20. Exp Biol Med (Maywood). 2014. PMID: 24951470 Free PMC article. Review.
Cited by
-
The Gut Microbiota Involvement in the Panorama of Muscular Dystrophy Pathogenesis.Int J Mol Sci. 2024 Oct 21;25(20):11310. doi: 10.3390/ijms252011310. Int J Mol Sci. 2024. PMID: 39457092 Free PMC article. Review.
-
Altered Gut Microbiome Composition in Dogs with Hyperadrenocorticism: Key Bacterial Genera Analysis.Animals (Basel). 2024 Oct 7;14(19):2883. doi: 10.3390/ani14192883. Animals (Basel). 2024. PMID: 39409832 Free PMC article.
-
Ethanol-induced changes to the gut microbiome compromise the intestinal homeostasis: a review.Gut Microbes. 2024 Jan-Dec;16(1):2393272. doi: 10.1080/19490976.2024.2393272. Epub 2024 Sep 3. Gut Microbes. 2024. PMID: 39224006 Free PMC article. Review.
-
Brain-Gut and Microbiota-Gut-Brain Communication in Type-2 Diabetes Linked Alzheimer's Disease.Nutrients. 2024 Aug 3;16(15):2558. doi: 10.3390/nu16152558. Nutrients. 2024. PMID: 39125436 Free PMC article. Review.
-
Restricted intake of sulfur-containing amino acids reversed the hepatic injury induced by excess Desulfovibrio through gut-liver axis.Gut Microbes. 2024 Jan-Dec;16(1):2370634. doi: 10.1080/19490976.2024.2370634. Epub 2024 Jun 27. Gut Microbes. 2024. PMID: 38935546 Free PMC article.
References
-
- Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018;390:2769–2778. - DOI
-
- Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12:720–727. - DOI
-
- Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology. 2017;152:313–321e2. - DOI
-
- Knights D, Lassen KG, Xavier RJ. Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome. Gut. 2013;62:1505–1510. - DOI
-
- Ward JBJ, Lajczak NK, Kelly OB, et al. Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon. Am J Physiol Gastrointest Liver Physiol. 2017;312:G550–G558. - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources